ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2023

FDA-approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness.

Elisa Canepa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.